A new study shows that the TissueCypher Barrett's Esophagus test significantly improves management of patients by nearly doubling appropriate care escalation for those at high risk of progressing to esophageal cancer, while reducing overtreatment in low-risk patients. The test uses advanced molecular analysis to better predict which patients with non-dysplastic Barrett's esophagus will develop serious conditions, enabling earlier and more precise interventions. This advancement could lead to better patient outcomes and more efficient use of medical resources in managing Barrett's esophagus.
TissueCypher Barrett's Esophagus test is the subject, with Pluang market data providing context. For readers following the health sector, here is Pluang's market snapshot as of Sep 15, 2026 16:41 WIB: Of 91 priced US health stocks, 35 rose and 48 fell. Notable movers include ACB at USD 3.92 (+2.89%), ENVB at USD 1.46 (-2.67%), and INO at USD 1.21 (+2.54%).
Chery unveiled its Globalisation 3.0 strategy at the 2026 International User Summit, aiming to transform from a traditional automaker into a high-tech integrated ecosystem by 2035. The strategy emphasizes AI adoption, green technologies, and local ma...
Unfair Links, founded by Rollo Unden and Oliver Fish, has launched a beta service providing local backlinks that are matched to a business's Google Business Profile, country, language, and page topic. Unlike generic backlinks, these links come from r...
Tango, a global live-streaming platform, has donated tens of thousands of dollars to support FRIDA Ukraine's mobile cancer screening program. This initiative brings essential cancer detection and preventive healthcare services directly to underserved...
California's upcoming AI safety mandate, effective May 15, 2027, is creating tension with federal military cybersecurity rules under the Defense Federal Acquisition Regulation Supplement (DFARS). Veteran-led engineering groups have developed advanced...
Greg Abel highlighted that every one-point increase in BNSF's profit margin translates to about $230 million in additional cash flow for Berkshire Hathaway. This underscores the significant impact BNSF's operational efficiency has on Berkshire's over...
